| CASE REPORT |
|
| Year : 2011 | Volume
: 1
| Issue : 1 | Page : 78-80 |
|
|
A case of neuroleptic malignant syndrome induced by desvenlafaxine in a patient on clozapine
Suddhendu Chakraborty1, Debasish Sanyal2, Bhaskar Mukherjee3, Sumit Roy4
1 Department of Psychiatry, KPC Medical College and Hospital, Kolkata, India
2 Department of Psychiatry , Calcutta National Medical College and Hospital, Kolkata, India
3 Department of Psychiatry , NRS Medical College and Hospital, Kolkata, Kolkata, India
4 Department of Cardiology, Calcutta National Medical College and Hospital, Kolkata, India, India
Correspondence Address:
Suddhendu Chakraborty
Department of Psychiatry, KPC Medical College and Hospital, Kolkata
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-0738.77537
|
|
|
Neuroleptic malignant syndrome is a rare and potentially serious syndrome associated with the use of many antipsychotic, antiparkinsonian, antidepressants, etc. Moreover, of the agents known to cause this entity, clozapine has been mentioned a fewer times, but desvenlafaxine has never been known to precipitate it. However in this study, we present a case of established Neuroleptic syndrome that precipitated after administration of desvenlafaxine in a patient of resistant schizophrenia who was on clozapine. The presenting case explores the possibility of the potential of desvenlafaxine in causing this rare clinical entity and also a possible idiosyncratic interaction between desvenlafaxine and clozapine, whose mechanism is yet to be known. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
